Drug Topics April 24, 2024
A Q&A with Douglas Hoey, CEO of NCPA, on ways to change the pharmacy payment model and deceptive practices being employed by PBMs.
Independent pharmacy profits have declined significantly recently, putting owners and pharmacists in a very difficult position. According to the National Community Pharmacists Association’s (NCPA) 2023 digest, gross profit margins for independent pharmacies that year fell to 21%, the lowest in 10 years.1 This is most likely due to a number of issues, including low or below-cost third-party reimbursements, inflation, and higher dispensing costs.
Douglas Hoey, CEO of NCPA, sat down with Drug Topics at the 2024 American Associated Pharmacies (AAP) Annual Conference to talk about different ways to change the current pharmacy payment model and deceptive practices...
Today's Sponsors
Today's Sponsor